-
Imclone lost its
separate identity in 2014 when its
former ImClone research and
manufacturing sites were
renamed Eli
Lilly and Company.
ImClone's stock...
- 2012. In 2004,
Stewart was
convicted of
felony charges related to the
ImClone stock trading case; she
served five
months in
federal prison for fraud...
-
personality Martha Stewart,
ImClone CEO
Samuel D. Waksal, and Stewart's
broker at
Merrill Lynch,
Peter Bacanovic.
ImClone's stock price dropped sharply...
- 1947) is the
founder and
former CEO of the
biopharmaceutical company ImClone Systems. He is also the
founder of
Kadmon Pharmaceuticals,
which was financed...
- of
Science in Israel,
challenged the Aventis-owned patent,
licensed by
Imclone, for the use of anti-epidermal
growth factor receptor antibodies in combination...
- of
ImClone stock.
ImClone shareholders then
filed class action lawsuits against the company.
Though not
covered by The
Cancer Letter, the
ImClone scandal...
- The Inflatables. Cuti
served as a
trial lawyer during Martha Stewart's
ImClone stock trading case,
alongside her lead
attorney Robert Morvillo. Stewart...
- that the company's
total ****ets had been
inflated by
around $11 billion.
ImClone's stock price dropped sharply at the end of 2001 when its drug Erbitux,...
- Quattrone; Joel L. Blumenfeld, a
Queens justice of the New York
Supreme Court;
ImClone founder and
chief executive Samuel D. Waksal; and New York
Governor David...
-
company was
founded in 2009 by
Samuel D. Waksal,
founder and
former CEO of
ImClone Systems, now
fully merged into Eli
Lilly and Company.
Waksal had served...
